Gary E. Deng, MD, PhD

Integrative Medicine Specialist

Medical Director, Integrative Medicine Service

Memorial Sloan Kettering Integrative Medicine Specialist Gary Deng
Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Telephone New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am an integrative medicine specialist who strives to inspire and empower people with cancer to make themselves strong in body, mind, and spirit. I incorporate some Eastern medicine approaches that are supported by scientific evidence and focus on nutrition, physical activity, stress management, sleep, and circadian rhythms. I advise patients on the proper use of herbs and dietary supplements so that they may experience potential benefits while avoiding harm. I lead the Integrative Medicine Clinical Program at Memorial Sloan Kettering and work closely with a team of highly professional therapists who provide acupuncture, massage therapy, mind-body therapies, yoga, qigong, exercise regimens, and music therapy — all tailored to the needs of cancer patients and survivors.


I am a principal investigator of several research projects on acupuncture, yoga, and botanical/herbal agents. To disseminate knowledge in this field, I supervise MSK’s Integrative Medicine Physician Education Program and write clinical practice guidelines and textbook chapters. I actively participate in the integrative medicine community by giving lectures internationally to professional and lay audiences, and by reviewing protocols, manuscripts, and grant applications in my field of expertise. I am a past president of the Society for Integrative Oncology.

  • Clinical Expertise: Preparing for Surgery; Post-Surgical Healing; Complementary Therapies for the Management of Chemotherapy Side Effects, Stress and Anxiety, Hot Flashes, Neuropathy, Lymphedema, Dry mouth, and Fatigue
  • Languages Spoken: English
  • Education: MD, Beijing Medical University (China); PhD, University of Miami
  • Residencies: The University of Texas Medical School at Houston
  • Board Certifications: Internal Medicine

See My Colleagues


Deng G, Cassileth B. Complementary or alternative medicine in cancer care-myths and realities. Nat Rev Clin Oncol. Nov 2013; 10(11):656-64

Deng GE, Rausch SM, Jones LW, et al. Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. May 2013; 143(5 Suppl): e420S-36S

Deng G, Wong WD, Guillem J, et al. A phase II, randomized, controlled trial of acupuncture for reduction of Postcolectomy Ileus. Ann Surg Oncol. Apr 2013; 20(4):1164-9.

Deng G, Kurtz RC, Vickers A, et al. A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients. J Ethnopharmacol. Apr 17 2011.

Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. May 20 2010; 28(15): 2565-2570

Deng G, Weber W, Sood A, Kemper KJ. Research on integrative healthcare: context and priorities. Explore (NY). May-Jun 2010; 6(3):143-158

Krasovsky J, Chang DH, Deng G, et al. Inhibition of human dendritic cell activation by hydroethanolic but not lipophilic extracts of turmeric (Curcuma longa). Planta Med. Mar 2009; 75(4): 312-315

Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. Journal of the Society for Integrative Oncology. Summer 2009; 7(3): 85-120

Deng G, Lin H, Seidman A, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol. Sep 2009; 135(9): 1215-1221

Cassileth BR, Rizvi N, Deng G, et al. Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients. Cancer Chemother Pharmacol. Dec 2009; 65(1): 67-71

Deng G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med. 2008;8:37

Deng G, Rusch V, Vickers A, et al. Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. J Thorac Cardiovasc Surg. Dec 2008;136(6):1464-1469

Ragupathi G, Yeung KS, Leung PC, et al. Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine. Sep 2 2008;26(37):4860-4865

Deng G. Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan Kettering Experience. Curr Oncol. Aug 2008;15 Suppl 2:s108 es168-171

Deng G, Vickers A, Yeung S, Cassileth B.. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.. Journal of Clinical Oncology Dec 31, 2007; 25(35) :5546-7

Deng GE, Cassileth BR, Cohen L, et al. Integrative Oncology Practice Guidelines. J Soc Integr Oncol. Spring 2007; 5(2):65-84

Vickers AJ, Feinstein MB, Deng GE, Cassileth BR. Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial [ISRCTN89462491]. BMC Palliat Care. Aug 18 2005;4:5

Deng G, Vickers A, Simon Yeung K, Cassileth BR. Acupuncture: integration into cancer care. Journal of the Society for Integrative Oncology. Spring 2006;4(2):86-92

Deng G, Cassileth BR. To what extent do cancer patients use complementary and alternative medicine? Nat Clin Pract Oncol. Oct 2005; 2(10): 496-497

Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Caner J Clin. Mar-Apr 2005: 55(2): 109-116

Deng, Cassileth BR, Yeung KS. complementary therapies for cancer-related symptoms. J Support Oncol. Sep-Oct 2004; 2(5): 491-426; discussion 427-429


Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.